Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Insulin Injection Therapy in Type 1 Diabetes Mellitus: 18-Month Follow-Up

Hissa, Miguel Nasser; Hissa, A; Bruin, Veralice Meireles Sales de; Fredrickson, Linda P.

doi:10.4158/ep.8.6.411

Cited by 7 publications

(5 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…China contributed with seven studies, 16–22 Colombia with five, 23–27 India with four, 28–31 Brazil 32–34 and Turkey 35–37 with three each, and Argentina, 38 Bosnia and Herzegovina, 39 Georgia, 40 Malaysia 41 and Mexico, 42 with one study each (Table 1). Only one report was published in 2002, 32 and the number of reports per year increased steadily, reaching eight reports in 2021, 17–19,22,26,31,40,42 and five reports up to July 2022 20,30,34,36,38 …”

Section: Resultsmentioning

confidence: 99%

“…China contributed with seven studies, [16][17][18][19][20][21][22] Colombia with five, [23][24][25][26][27] India with four, [28][29][30][31] Brazil [32][33][34] and Turkey [35][36][37] with three each, and Argentina, 38 Bosnia and Herzegovina, 39 Georgia, 40 Malaysia 41 and Mexico, 42 with one study each (Table 1). Only one report was published in 2002, 32 and the number of reports per year increased steadily, reaching eight reports in 2021, [17][18][19]22,26,31,40,42 and five reports up to July 2022. 20,30,34,36,38 Overall, seven reports presented results of experimental studies (five randomized trials and two quasiexperimental [pre-post]) 16,17,19,22,27,41,…”

Section: Characteristics Of Sources Of Evidencementioning

confidence: 99%

See 1 more Smart Citation

Use of continuous glucose monitors in low‐ and middle‐income countries: A scoping review

et al. 2023

View full text Add to dashboard Cite

Aims:The use of continuous glucose monitors (CGMs) has been shown to have positive impact on diabetes management for people with type 1 diabetes (T1DM), type 2 diabetes (T2DM) and gestational diabetes (GDM) in high-income countries. However, as useful as CGMs are, the experience in low-and middle-income countries (LMICs) is limited and has not been summarized. Methods:A scoping review of the scientific literature was conducted. Medline, Embase, Global Health and Scopus were used to seek original research conducted in LMICs. The search results were screened by two reviewers independently. We included studies assessing health outcomes following the use of CGMs at the individual level (e.g. glycaemic control or complications) and at the health system level (e.g. barriers, facilitators and cost-effectiveness) in English, Portuguese, Spanish and French. Results were summarized narratively.Results: From 4772 records found in database search, 27 reports were included; most of them from China (n = 7), Colombia (n = 5) and India (n = 4). Thirteen reports studied T1DM, five T2DM, seven both T1DM and T2DM and two GDM.Seven reports presented results of experimental studies (five randomized trials and two quasi-experimental); two on cost-effective analysis and the remaining 18 were observational. Studies showed that CGMs improved surrogate glycaemic outcomes (HbA 1c reduction), hard endpoints (lower hospitalization rates and diabetes complications) and patient-oriented outcomes (quality of life). However, several caveats were identified: mostly observational studies, few participants in trials, short follow-up and focused on surrogate outcomes. Conclusions:The scoping review identified that studies about CGMs in LMICs have several limitations. Stronger study designs, appropriate sample sizes and the inclusion of patient-important outcomes should be considered to inform the evidence about CGMs for the management of people with diabetes in LMICs.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Characteristics Of Sources Of Evidencementioning

confidence: 99%

Use of continuous glucose monitors in low‐ and middle‐income countries: A scoping review

et al. 2023

View full text Add to dashboard Cite

show abstract

“…A Brazilian study carried out in the state of Ceará with adolescents and young adults showed improvement of glucose control in type 1 diabetes patients after the change from conventional treatment or multiple doses to pump infusion therapy. 34 The need for intensive treatment in diabetes mellitus is clear. Currently, this is done so as to avoid the fearsome complications of this chronic disease.…”

Section: Pump Infusion Vs Multiple Insulin Dosesmentioning

confidence: 99%

Insulin-Pump Therapy for Type 1 Diabetes Mellitus

Blumer

Edelman²,

Hirsch³

2012

N Engl J Med

View full text Add to dashboard Cite

show abstract

“…Estudo brasileiro envolvendo adolescentes e adultos jovens, realizado no Ceará, mostrou melhora do controle glicêmico nos diabéticos tipo 1 após a passagem de tratamento convencional ou múltiplas doses para utilização de bomba de infusão de insulina 34 .…”

Section: Comparação Entre Bomba E Múltiplas Doses De Insulinaunclassified